Serum microarrays for large scale screening of protein levels.
Author(s): Janzi M, Odling J, Pan-Hammarström Q, Sundberg M, Lundeberg J, Uhlén M, Hammarström L, Nilsson P
Publication: Mol Cell Proteomics, 2005, Vol. 4, Page 1942-7
PubMed ID: 16131484 PubMed Review Paper? No
Purpose of Paper
Conclusion of Paper
Studies
-
Study Purpose
The purpose of this study was to determine the effects of analysis method and freeze-thaw cycling on serum IgA and C3 concentrations. Specimens were collected between 1999 and 2002 and stored at -20 degrees C.
Summary of Findings:
One freeze-thaw cycle led to significant deviations in IgA measurements which were larger for specimens with lower initial IgA concentrations (56% for <0.07 mg/mL IgA) than for specimens with higher initial IgA concentrations (12% for >0.07-4.9 mg/mL IgA and 31% for >5 mg/mL IgA). However, the authors note that the lower concentrations of IgA were initially measured by radial immunodiffusion which has a lower limit of detection than nephelometry which was used for measurement after the freeze-thaw cycle. Nephelometric determination of IgA at high concentrations (>5 mg/mL) showed increased variation, and these specimens were excluded from analysis. The authors state that a high level of correlation was observed between serum microarray and nephelometric analysis of serum IgA levels. 65 of 1964 specimens (3.3%) showed greater than 5-fold deviation between IgA measurements taken by each method. 31 of these specimens had higher values on the array, but very low measurements (median 0.02 mg/mL) and 34 had higher values by nephelometry. Similar correlations between serum microarray and nephelometric analysis were observed for the measurement of C3.
Biospecimens
Preservative Types
- Frozen
Diagnoses:
- Other diagnoses
- Not specified
Platform:
Analyte Technology Platform Protein Reverse phase protein microarray Protein Radial immunodiffusion assay Protein Clinical chemistry/auto analyzer Pre-analytical Factors:
Classification Pre-analytical Factor Value(s) Preaquisition Diagnosis/ patient condition Increased susceptibility to infection
Preaquisition Biomarker level Increased IgA levels
Normal IgA levels
Low IgA levels
Reverse phase protein microarray Specific Targeted peptide/protein IgA
C3
Clinical chemistry/auto analyzer Specific Technology platform Radial immunodiffusion assay
Serum microarray
Storage Freeze/thaw cycling 0 cycles
1 cycle